. Author manuscript; available in PMC: 2016 Jul 4.

Published in final edited form as: Kidney Int. 2016 Jan 4;89(1):95–104. doi: 10.1038/ki.2015.315

Table 3.

Histomorphometry

Tibia	Normal (n=8)	CKD (Vehicle) (n=9)	CKD (Raloxifene) (n=10)
MAR (μm/day)^¶	1.305 ± 0.185	2.470 ± 0.569	1.890 ± 0.511
MS/BS (%)^§	26.56 ± 5.14	33.32 ± 4.11	23.89 ± 4.75 ^#
BFR/BS (μm³/μm²/year)^¶	126.65 ± 31.02	299.62 ± 74.35 ^*	170.40 ± 78.52 ^#
Oc.S/BS (%)^¶	7.157 ± 1.250	15.739 ± 3.332 ^*	15.684 ± 6.857 ^*
N.Oc/BS (1/mm)^§	1.966 ± 0.412	4.125 ± 0.785 ^*	4.134 ± 1.653 ^*
Vertebra	Normal (n=8)	CKD (Vehicle) (n=9)	CKD (Raloxifene) (n=10)
MAR (μm/day)^¶	1.057 ± 0.339	1.983 ± 0.876	1.574 ± 0.400
MS/BS (%)^§	13.62 ± 3.98	27.81 ± 5.73 ^*	16.21 ± 3.73 ^#
BFR/BS (μm³/μm²/year)^¶	52.14 ± 21.76	211.94 ± 128.49 ^*	94.19 ± 39.80 ^#

^§

One-Way ANOVA followed by Fisher’s LSD tests

^¶

Kruskal-Wallis test followed Mann-Whitney U tests (with Bonferroni correction)

vs. Normal

vs. CKD (Vehicle)